Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
This study has been terminated.
Sponsor:
Pfizer
Collaborator:
Aventis Pharmaceuticals
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00240747
First received: October 14, 2005
Last updated: May 24, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | January 2005 |
| Estimated Primary Completion Date: | No date given |